Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer have?
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer has 173 citations in the OpenAlex counts ScholarIQ stores.
When was Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer published?
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer?
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer has gold oa status in the ScholarIQ index.
What is the DOI of Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer?
The DOI for Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer is on the source record.
What is the PMID of Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer?
The PMID for Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer is on the source record.
What is the OpenAlex record for Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer?
The OpenAlex for Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer is on the source record.